Spectrum of Orthopaedic Problems in Patients with Movement Disorders: A Systematic Review of Clinical Manifestations
Objective: To identify and summarizes the spectrum of orthopedic problems reported in patients with movement disorders Background: Movement disorders such as Parkinson's disease, Dystonia, Essential tremor,…Psychiatric manifestations in premanifest Huntington’s disease as early indicators of motor onset: a systematic review
Objective: To identify and analyze psychiatric manifestations acting as early indicators in individuals carrying the HTT gene mutation during the premanifest stage, evaluating their prevalence…Psychotic Symptoms and Cognitive Impairment in Huntington’s Disease
Objective: To investigate the clinical and cognitive correlates of psychotic symptoms in patients with Huntington’s disease (HD). Background: Psychiatric manifestations are common in HD, but…Clinical Profile and Key Correlates of Genetic Load, Motor Severity, and Caregiver Burden in an Iranian Huntington’s Disease Cohort
Objective: To characterize an Iranian Huntington’s disease (HD) cohort and quantify associations between CAG repeat length, age at onset, motor severity, and caregiver burden. Background:…Clinical and Phenotypic Features of Concurrent Huntington’s Disease and Amyotrophic Lateral Sclerosis: A Case Series
Objective: To describe the clinical and phenotypic features of patients with concurrent Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), and to examine HD patients…Antidepressants in Huntington’s Disease: A Meta Analysis of Mood and Motor Outcomes with Placebo-controlled Trials
Objective: To evaluate the efficacy of antidepressants for depression in Huntington’s disease (HD). Background: Depression is highly prevalent in HD. Despite frequent clinical use of…Depressive Symptoms and Functional Impairment in Huntington’s Disease A Brazilian Cohort Study
Objective: To investigate the prevalence of psychiatric manifestations in Huntington’s disease (HD) and examine their association with functional disease stages. Background: HD is an autosomal…Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease
Objective: To compare the efficacy and safety of tetrabenazine, deutetrabenazine, and valbenazine for chorea and neuropsychiatric outcomes in Huntington’s disease (HD). Background: Vesicular monoamine transporter…Psychiatric Symptoms and Quality of Life in Huntington’s Disease Evidence from a Brazilian Cohort
Objective: To investigate the association between psychiatric manifestations and perceived quality of life in patients with Huntington’s disease (HD). Background: HD is a progressive neurodegenerative…Anti-IgLON5 Encephalitis Presenting as Chronic Progressive Asymmetrical Ataxia and Chorea
Objective: To report a case of gait instability and progressive asymmetrical chorea clinically confirmed as anti-IgLON5 encephalitis. Background: Anti-IgLON5 encephalitis is a rare autoimmune neurological…
- 1
- 2
- 3
- …
- 25
- Next Page »